Triticum Exploitatie

Triticum Exploitatie is a biotechnology company focused on the development and commercialization of pharmaceutical products derived from Triticum vulgare (wheat) extracts. The company's primary technology revolves around Rigenase, a specific wheat germ extract used to promote tissue regeneration and wound healing. Its flagship products, such as Fitostimoline, are widely used in the treatment of burns, sores, and various dermatological conditions. Triticum Exploitatie operates as part of a broader network associated with the Italian pharmaceutical group Farmaceutici Damor, leveraging plant-based biologics to address unmet needs in skin repair. The company's research emphasizes the stimulation of fibroblast activity and protein synthesis to accelerate the natural healing process of the skin. Its products are available in various formulations, including creams, gels, and impregnated gauze, catering to both clinical and over-the-counter markets.